Simvastatin inhibits the proliferation of A549 lung cancer cells through oxidative stress and up-regulation of SOD2

Pharmazie

Volumn 69, Issue 8, 2014, Pages 610-614

  Li, Yanjie ^a   Fu, Jieqin ^a   Yuan, Xue ^a   Hu, Changhua ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SUPEROXIDE DISMUTASE;

A549 CELL LINE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MTT ASSAY; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIMVASTATIN; SUPEROXIDE DISMUTASE;

EID: 84906728269     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.4508     Document Type: Article

References (27)

1. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 5: 2223-2229.
2. Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C, Dutrillaux B (1992) SOD2: a new type of tumor-suppressor gene? Int J Cancer 51: 476-480.
3. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM (1993) Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. P Natl Acad Sci USA 90: 3113-3117.
4. Cyr AR, Hitchler MJ, Domann FE (2013) Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics. Antioxid Redox Sign 18: 1946-1955.
5. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38.
6. Demierre MF, Higgins PDR, Gruber SB, Hawk E, Lippman SM (2005) Statins and cancer prevention. Nat Rev Cancer 5: 930-942.
7. Endo, A (1976) ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot 29: 1346-1348.
8. Feleszko W, Ba?kowiec EZ, Sieberth E, Marczak M, Dabrowska A, Giermasz A, Czajka A, Jakóbisiak M (1999) Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-rastransformed murine tumor via inhibition of tumor-induced angiogenesis. Int J Cancer 81: 560-567.
9. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343: 425-430.
10. Han L, Lee SW, Yoon JH, Park YG, Choi YJ, Nam SW, Lee JY, Wang YP, Park WS (2013) Association of SOD1 and SOD2 single nucleotide polymorphisms with susceptibility to gastric cancer in a Korean population. Apmis 121: 246-256.
11. Hitchler MJ, Domann FE (2009) Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radical Bio Med 47: 115-127.
12. Hoque A, Chen HL, Xu XC (2008) Statin Induces Apoptosis and Cell Growth Arrest in Prostate Cancer Cells. Cancer Epidem Biomar 17: 88-94.
13. HuCH, Deng C, Mackovski N, Long L, Zhu CS,YangY,Wang YG, Chen JZ, HuangXF,WangQ(2010) Effects of simvastatin and 6-hydroxydopamine on histaminergic H1 receptor binding density in rat brains. Prog Neuro- Psychoph 34: 1419-1425.
14. Jorgenson TC, Zhong WW, Oberley TD (2013) Redox Imbalance and Biochemical Changes in Cancer. Cancer Res 73: 6118-6223.
15. Khanzada UK, Pardo OE, Meier C, Downward J, Seckl MJ, ArcaroA(2005) Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signaling. Oncogene 255: 877-887.
16. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes D, Daumer KM, Lin Z, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Knudsen ES, Sotgia F, Lisanti MP (2010) Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 9: 3256-3276.
17. McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP (2001) Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. Qjm-Int J Med 94: 485-490.
18. Rigas B, SunY(2008) Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Brit J Cancer 98: 1157-1160.
19. Sánchez CA, Rodŕguez E, Varela E, Zapata E, Páez A, Massó FA, Monta2no LF, López-Marure R (2008) Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest 26: 698-707.
20. Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, Martinez- Outschoorn UE, Pavlides S, Howell A, Iozzo RV, Pestell RG, Scherer PE, Capozza F, Lisanti MP (2011) Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 11: 383-394.
21. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T (1998) Protein-bound acrolein: Potential markers for oxidative stress. P Natl Acad Sci USA 95: 4882-4887.
22. ValkoM, Rhodes CJ, Moncol J, Izakovic M, MazurM(2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem-Biol Interact 160: 1-40.
23. Wöchtershöuser A, Akoglu B, Stein J (2001) HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22: 1061-1967.
24. Wang L, Hu CH (2010) The new machanisms of statins' anticancer effects. Chin Pharm J 45: 1976-1979.
25. Xing W, Deng C, Hu CH (2010) Molecular cloning and characterization of the global regulator LaeA in Penicillium citrinum. Biotechnol Lett 32: 1733-1737.
26. Xu Z, Zh HX, Luk JM, Wu DM, Gu DY, Gong WD, Tan YF, Zhou JW, Tang JH, Zhang ZD (2012) Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer 118: 5489-5496.
27. Zhao YF, Oberley TD, Chaiswing L, Lin SM, Epstein CJ, Huang TT, Clair DS (2000) Manganese superoxide dismutase deciency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53- mediated pathways in a skin cancer model. Oncogene 21: 3836-3846.